Apr 12, 2022 06:37AM Needham & Company Reiterates Buy Rating, $48 Price Target on Xenon Pharmaceuticals (XENE), Sees 70% Probability of Success for XEN1101

Apr 4, 2022 04:01PM Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

Apr 4, 2022 04:01PM Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

Apr 8, 2021 04:03PM Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

Apr 8, 2021 04:03PM Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

Mar 12, 2021 12:19PM Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Mar 12, 2021 12:19PM Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Mar 10, 2021 05:49AM Xenon Pharmaceuticals (XENE) Prices 4.32M Share Common Offering at $18.50/Sh

Mar 10, 2021 12:49AM Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering

Mar 10, 2021 12:49AM Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering

Mar 9, 2021 04:05PM Xenon Pharmaceuticals (XENE) to Offer Common Stock

Mar 9, 2021 04:04PM Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares

Mar 9, 2021 04:04PM Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares

Mar 2, 2021 08:09AM Xenon Pharmaceuticals (XENE) PT Raised to $25 at Needham & Company

Jul 21, 2020 09:30AM Pre-Open Movers 07/21: (NBEV) (LXRX) (OMI) Higher; (ACAD) (PIRS) (CTSO) Lower (more...)

Jul 21, 2020 09:25AM UPDATE: Needham & Company Starts Xenon Pharmaceuticals (XENE) at Buy

Mar 31, 2016 04:30PM Xenon Pharmaceuticals to Provide Business and Milestone Update at Needham Healthcare Conference